Pasithea Therapeutics Corp (KTTA)
6.550
-0.05
(-0.72%)
USD |
NASDAQ |
May 23, 16:00
6.78
+0.23
(+3.51%)
Pre-Market: 20:00
Pasithea Therapeutics Price to Book Value: 0.3437 for May 23, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 23, 2024 | 0.3437 |
| May 22, 2024 | 0.3462 |
| May 21, 2024 | 0.3465 |
| May 20, 2024 | 0.3489 |
| May 17, 2024 | 0.3463 |
| May 16, 2024 | 0.341 |
| May 15, 2024 | 0.3489 |
| May 14, 2024 | 0.3489 |
| May 13, 2024 | 0.3646 |
| May 10, 2024 | 0.4029 |
| May 09, 2024 | 0.4029 |
| May 08, 2024 | 0.3699 |
| May 07, 2024 | 0.3741 |
| May 06, 2024 | 0.3741 |
| May 03, 2024 | 0.3631 |
| May 02, 2024 | 0.3631 |
| May 01, 2024 | 0.3631 |
| April 30, 2024 | 0.3631 |
| April 29, 2024 | 0.3631 |
| April 26, 2024 | 0.3799 |
| April 25, 2024 | 0.3799 |
| April 24, 2024 | 0.3646 |
| April 23, 2024 | 0.372 |
| April 22, 2024 | 0.3547 |
| April 19, 2024 | 0.373 |
| Date | Value |
|---|---|
| April 18, 2024 | 0.3751 |
| April 17, 2024 | 0.3751 |
| April 16, 2024 | 0.3804 |
| April 15, 2024 | 0.3751 |
| April 12, 2024 | 0.3914 |
| April 11, 2024 | 0.4014 |
| April 10, 2024 | 0.4302 |
| April 09, 2024 | 0.4326 |
| April 08, 2024 | 0.4433 |
| April 05, 2024 | 0.446 |
| April 04, 2024 | 0.4591 |
| April 03, 2024 | 0.4192 |
| April 02, 2024 | 0.3793 |
| April 01, 2024 | 0.3804 |
| March 28, 2024 | 0.323 |
| March 27, 2024 | 0.3185 |
| March 26, 2024 | 0.3252 |
| March 25, 2024 | 0.3177 |
| March 22, 2024 | 0.2984 |
| March 21, 2024 | 0.3193 |
| March 20, 2024 | 0.3028 |
| March 19, 2024 | 0.3037 |
| March 18, 2024 | 0.3168 |
| March 15, 2024 | 0.3105 |
| March 14, 2024 | 0.3206 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.2056
Minimum
Dec 20 2023
98.89
Maximum
Sep 15 2021
1.990
Average
0.4378
Median
Aug 04 2023
Price to Book Value Benchmarks
| CEL-SCI Corp | 4.808 |
| AIM ImmunoTech Inc | 4.920 |
| IGC Pharma Inc | 3.450 |
| NovaBay Pharmaceuticals Inc | -- |
| Protalix BioTherapeutics Inc | 2.904 |
Price to Book Value Related Metrics
| Price | 6.550 |
| Earnings Yield | -212.4% |
| Market Cap | 6.833M |